ARCHIVES

Tuck To Direct Clinical Trials At Yale; Arceci Joins Hopkins.

This article is from The Cancer Letter archive.

Vol. 26 No. 37 | October 13, 2000

Download PDF Visit The Full Archive

Related Articles

Aggressive, Tailored Therapy Improves Survival, Study Finds

October 31, 2008

ACS Increases Funding for Scholar Grants; NCI Posts Interim FY2001 Funding Policy.

December 1, 2000

Cancer Biomarker Research “Piecemeal and Unorganized,” IOM Report Finds.

April 6, 2007

Taxol Plus Carboplatin Increased Survival Of NSCLC In Patients 70 And Older

June 25, 2010

Senate approves $1 billion increase for NIH; 3.7% raise is smallest since 1995.

September 19, 2003

In Brief: Baylor Campus to Build Joint Cancer Center

January 17, 2014